Jeffrey Skolnik | Senior Vice President Of Clinical Development
Inovio Pharmaceuticals

Jeffrey Skolnik, Senior Vice President Of Clinical Development, Inovio Pharmaceuticals

Dr. Skolnik leads INOVIO’s clinical development programs, focusing on HPV and immuno-oncology DNA medicines. He is a key member of the leadership team overseeing these global clinical assets. Dr. Skolnik has held several leadership positions in Clinical Development and Medical Affairs for AstraZeneca, GSK, and TetraLogic Pharmaceuticals, for both early- and late-stage compounds. Dr. Skolnik is a board-certified pediatric hematologist/oncologist and is an Attending Physician at the Children’s Hospital of Philadelphia.


Day 1 - November 28 @ 17:20

INO-3107 program for the treatment of Recurrent Respiratory Papillomatosis

Day 2 - November 29 @ 16:30

Panel: Unleashing the Power of Cancer Vaccines: Strategies for the Future

last published: 02/Jan/24 12:15 GMT

back to speakers